Akman A, Aydin P
Başkent University Faculty of Medicine, Department of Ophthalmology, Ankara, Turkey.
Eye (Lond). 1999 Oct;13 ( Pt 5):653-5. doi: 10.1038/eye.1999.177.
To determine whether the mydriatic efficacy of spray application of tropicamide 1% is comparable to drop instillation of tropicamide 1%, and to compare the ocular discomfort caused by these methods.
Thirty-four healthy volunteers were randomly assigned to one of two groups, and received either a single drop of tropicamide 1% eye drops or a single puff of tropicamide 1% spray into open eyes. Pupil diameters were measured from anterior segment images taken using a Topcon Imagenet system at baseline and at the fifth, tenth and fifteenth minute after drug administration. Ocular discomfort experienced with each method was also compared.
Repeated measures analysis of variance revealed that a statistically significant increase in pupil diameter was achieved with both application methods over time (p < 0.0001), and that there were no statistically significant differences in pupil diameter between the two groups at each time point (p = 0.409). The mean ocular discomfort score for tropicamide 1% spray was 1.45 +/- 0.56, and for tropicamide 1% eye drops was 2.71 +/- 0.67. This difference was statistically significant (p < 0.001).
The mydriatic efficacy of tropicamide 1% spray is similar to that of conventional tropicamide 1% eye drops, and spray application causes less ocular discomfort.
确定1%托吡卡胺喷雾给药的散瞳效果是否与1%托吡卡胺滴眼液滴眼相当,并比较这两种方法引起的眼部不适。
34名健康志愿者被随机分为两组,分别接受一滴1%托吡卡胺滴眼液滴眼或向睁开的眼睛单次喷入一次1%托吡卡胺喷雾。使用拓普康Imagenet系统在给药前及给药后第5、10和15分钟拍摄眼前节图像,测量瞳孔直径。同时比较两种方法引起的眼部不适。
重复测量方差分析显示,两种给药方法均使瞳孔直径随时间有统计学意义的增加(p<0.0001),且两组在各时间点的瞳孔直径无统计学显著差异(p = 0.409)。1%托吡卡胺喷雾的平均眼部不适评分为1.45±0.56,1%托吡卡胺滴眼液为2.71±0.67。这种差异具有统计学意义(p<0.001)。
1%托吡卡胺喷雾的散瞳效果与传统的1%托吡卡胺滴眼液相似,但喷雾给药引起的眼部不适更少。